When it was Alex Karp‘s turn to speak on Palantir’s second-quarter earnings call Monday evening, the CEO could barely contain his excitement. Grinning as he repeatedly pounded his pen on the table—and
Timothy P. Moran, Chief Business Officer at Kestra Medical Technologies, Ltd. (), sold a total of 15,256 common shares of the company’s stock across three transactions from July 30 to August 3, 2026. The sales amounted to a total
This is an edition of the Markets P.M. newsletter, a recap of the day’s most important markets moves, delivered after the closing bell. If you’re not subscribed, sign up here. What Happened
Nikhil Ramesh Mehta, a director at F5, Inc. (), sold a total of 3,900 shares of the company’s common stock on July 30, 2026. The transactions amounted to approximately $1,555,795, with share prices ranging from $386.50 to $391.935. The stock has
George Santos, the former lawmaker convicted of fraud, got in fresh trouble following his release from prison by making illegal bets on Kalshi. Then, hours after the Commodity Futures Trading Commission ordered the former U.
Horizon Kinetics Asset Management LLC, a 10% owner and director of Texas Pacific Land Corp (), acquired common stock in the company on July 31, 2026. The firm purchased 1 share at a price of $400.09, totaling $400 for the transaction. The
0940 GMT – Stellantis has made too little progress on its U.S. turnaround, despite a solid market backdrop, UBS analyst Patrick Hummel writes. Elevated dealer stock levels could require production cuts, higher incentives or a mixture
Andrea Robertson, a director at Clean Harbors Inc. (), sold 789 shares of the company’s common stock on August 3, 2026. The transaction was executed at a price of $314.01 per share, totaling $247,753. Following this transaction, Robertson directly holds 8,979
Laura C. Kendall, a director at HomeTrust Bancshares, Inc. (), recently sold 10,000 shares of common stock for a total value of $511,348. The transactions, which occurred on July 30, 2026, also included the acquisition of 10,000 shares through the exercise
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0811 GMT – A potential tie-up between AstraZeneca and Bristol Myers Squibb could face antitrust hurdles due
